VivoSim Labs, Inc. Form PRE 14A: Preliminary proxy statement
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2026-08-10: Form PRE 14A; Period of report 2026-09-30; Description PRE 14A; Document d143745dpre14a.htm.
- 2024-09-18: Form PRE 14A; Period of report 2024-09-18; Description PRE 14A; Document onvo-20240918.htm.
- 2023-07-14: Form PRE 14A; Period of report 2023-09-14; Description PRE 14A; Document onvo-20230714.htm.
- 2020-07-24: Form PRE 14A; Period of report 2020-07-24; Description PRE 14A; Document onvo-pre14a_20200724.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2026-08-10 | PRE 14A | 2026-09-30 | PRE 14A | d143745dpre14a.htm |
| 2024-09-18 | PRE 14A | 2024-09-18 | PRE 14A | onvo-20240918.htm |
| 2023-07-14 | PRE 14A | 2023-09-14 | PRE 14A | onvo-20230714.htm |
| 2020-07-24 | PRE 14A | 2020-07-24 | PRE 14A | onvo-pre14a_20200724.htm |
| 2019-07-09 | PRE 14A | 2019-09-05 | PRE 14A | onvo-pre14a_20190905.htm |
| 2018-06-01 | PRE 14A | 2018-07-26 | PRE 14A | onvo-pre14a_20180601.htm |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |